Virtus LifeSci Biotech Products ETF
12 hedge funds and large institutions have $3.13M invested in Virtus LifeSci Biotech Products ETF in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Morgan Stanley
New York
|
$774K |
2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$981K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$26K |
Top Sellers
1 |
1
LPL Financial
San Diego,
California
|
$283K |
2 |
2
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$868K |